Search - tctmd.com

Displaying 61 - 80 of 152

Sort: Relevancy | Date

News Conference News ADA 2023

Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1

Shelley Wood

June 29, 2023

News Conference News ADA 2023

Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide

L.A. McKeown

June 28, 2023

News Features

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

L.A. McKeown

May 12, 2023

News Daily News

To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC

Yael L. Maxwell

April 12, 2023

News Daily News

Inactivity Pandemic Poised to Undo CVD Prevention Advances

Michael O'Riordan

April 11, 2023

News Daily News

Regaining Weight Won’t Erode CV Risk Factor Benefits Short Term

L.A. McKeown

March 31, 2023

News Conference News ACC 2023

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Michael O'Riordan

March 14, 2023

News Daily News

Longer-Term ASCVD Risk Assessment Best for Younger Patients

Michael O'Riordan

February 16, 2023

News Daily News

Autism and Cardiometabolic Disease Often Go Hand in Hand

Caitlin E. Cox

February 06, 2023

News Daily News

Obesity and CVD: New Review Highlights Where Tools and Meds Fall Short

Shelley Wood

January 31, 2023

News Daily News

Total Meals, Not Timing, Drives Long-term Body Weight Changes

Todd Neale

January 24, 2023

News Daily News

Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS

Michael O'Riordan

December 30, 2022

News Daily News

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Michael O'Riordan

December 14, 2022

News Daily News

Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements

Michael O'Riordan

December 07, 2022

News Daily News

Intermittent Fasting Trial Comes Out (Partly) Positive, but CV Impact Mixed

Todd Neale

August 12, 2022

News Daily News

Cardiorespiratory Fitness Is Key to Longevity, Regardless of Age, Sex, and Race

Yael L. Maxwell

August 09, 2022

News Daily News

Meat Consumption and Gut Microbiome Linked to ASCVD Risk

Yael L. Maxwell

August 03, 2022

News Daily News

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

Michael O'Riordan

July 05, 2022

News Daily News

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

L.A. McKeown

June 09, 2022

News Daily News

Diet Drinks May Help With Weight Loss and Cardiometabolic Control

L.A. McKeown

March 17, 2022

Advertisement

Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1

Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC

Inactivity Pandemic Poised to Undo CVD Prevention Advances

Regaining Weight Won’t Erode CV Risk Factor Benefits Short Term

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Longer-Term ASCVD Risk Assessment Best for Younger Patients

Autism and Cardiometabolic Disease Often Go Hand in Hand

Obesity and CVD: New Review Highlights Where Tools and Meds Fall Short

Total Meals, Not Timing, Drives Long-term Body Weight Changes

Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements

Intermittent Fasting Trial Comes Out (Partly) Positive, but CV Impact Mixed

Cardiorespiratory Fitness Is Key to Longevity, Regardless of Age, Sex, and Race

Meat Consumption and Gut Microbiome Linked to ASCVD Risk

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

Diet Drinks May Help With Weight Loss and Cardiometabolic Control

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content